USFDA completes inspection of Strides Pharma Bengaluru plant
Team Udayavani, Jul 20, 2019, 6:13 PM IST
Image for Representation
Bengaluru: Drug firm Strides Pharma Science said on Saturday the inspection of its formulation facility in Bengaluru by the US health regulator has completed successfully with a voluntary action indicated (VAI) classification.
The company’s facility in Bengaluru underwent a United States Food and Drug Administration (USFDA) inspection that ended on May 24, 2019, Strides Pharma Science said in a statement.
The Bengaluru facility is the largest manufacturing facility for the company with capabilities to produce finished dosage formulation products across multiple dosage formats including tablet, capsules, ointments, creams and liquids, Strides Pharma said.
The facility services key regulated markets of the US, Europe, and Australia, it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Karnataka Women’s Commission demands high-level probe against BJP MLC C T Ravi
Tulu cinema ‘Daskath’ brings struggles of village life to big screen
Grant 0.5 per cent interim reservation to transgenders, Karnataka HC tells NLSIU
Police up vigilance amid concerns over drug abuse during New Year celebrations
IIM Bangalore director and 7 others booked over caste discrimination against Dalit professor
MUST WATCH
Latest Additions
Karnataka Women’s Commission demands high-level probe against BJP MLC C T Ravi
‘All We Imagine As Light’ leads Barack Obama’s 2024 recommended movies list
GST Council meet to decide on lower taxes on insurance policies, ATF inclusion
Raut residence recce: 4 staffers of telecom services firm interrogated, released after verification
Tulu cinema ‘Daskath’ brings struggles of village life to big screen
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.